Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

Published:2011-09 Issue:14 Volume:47 Page:2117-2127
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kudo Masatoshi,Imanaka Kazuho,Chida Nobuyuki,Nakachi Kohei,Tak Won-Young,Takayama Tadatoshi,Yoon Jung-Hwan,Hori Takeshi,Kumada Hiromitsu,Hayashi Norio,Kaneko Shuichi,Tsubouchi Hirohito,Suh Dong Jin,Furuse Junji,Okusaka Takuji,Tanaka Katsuaki,Matsui Osamu,Wada Michihiko,Yamaguchi Iku,Ohya Toshio,Meinhardt Gerold,Okita Kiwamu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. The 2008 Okuda lecture management of hepatocellular carcinoma: from surveillance to molecular targeted therapy;Kudo;J Gastroenterol Hepatol,2010

2. Hepatocellular carcinoma in the Asia-Pacific region;Yuen;J Gastroenterol Hepatol,2009

3. Asia-Pacific working party on prevention of hepatocellular carcinoma. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol 2010;25:657–63.

4. Hepatocellular carcinoma;Llovet;Lancet,2003

5. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan;Makuuchi;World J Gastroenterol,2006

Cited by 490 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapies for Hepatocellular Carcinoma Treatment;Liver Cancer - Multidisciplinary Approach;2024-09-11

2. Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies;World Journal of Gastrointestinal Oncology;2024-07-15

3. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

4. Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts;Cancers;2024-06-28

5. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27